Introduction
The thorough research provides a succinct overview of the current market conditions, taking into account other elements including market dynamics, growth and restraining factors, challenges, and opportunities within the analysis time frame. Additionally, the study includes thorough industry statistics that help new players better comprehend the current state of the business.
Definition
The discovery that arthritic conditions resulted in a decrease in hyaluronan’s average molecular weight and concentration led to the development of the therapeutic paradigm known as viscosupplementation for the long-term relief of pain in human and animal joints with osteoarthritis or traumatic arthritis. As a result, the synovial fluid’s elastoviscous qualities are significantly diminished. Viscosupplementation is a therapeutic procedure in which the pathological synovial fluid or effusion is removed from the joint by arthrocentesis and substituted with a highly purified hyaluronan solution that has a concentration of hyaluronan that is 16–30 times higher than that of the pathological joint fluid and 2–5 times higher than that of the hyaluronan in healthy synovial fluid. The rheological characteristics (viscosity and elasticity) of several hyaluronan preparations utilized now for medicinal reasons are poor. As a result, the fluid’s elasto viscosity is comparable to fluid taken out of an arthritic joint.
Another product made of hyaluronan derivatives with significantly higher elastoviscosity than hyaluronan solutions is readily available to patients all over the world. Its rheological characteristics are similar to those of young, healthy people’s fluid. In arthritic joints, viscosupplementation provides long-lasting pain alleviation.
Benefits of Using Viscosupplementation
In the US, osteoarthritis affects more than 30 million individuals and is a debilitating ailment that is common. When it happens in joints, wear and strain over time results in the degeneration of the joint. The cartilage in your joint, which cushions bones to minimise friction between them, is destroyed by osteoarthritis. Walking or other activities may become painful as a result of this bone-to-bone contact.
Your healthcare professional will provide hyaluronic acid injections into your joint as part of the viscosupplementation therapy for arthritis. Your arthritic joint may experience less pain and swelling thanks to this viscous fluid (most commonly, your knee).
The ends of the bones that make up your joints often have a cartilage cap. Your bones should slide against each other smoothly thanks to this cartilage. A hyaluronic acid-containing fluid coats this cartilage. In your joint, this functions as a lubricant and a shock absorber.
Your doctor will provide a hyaluronic acid injection during viscosupplementation therapy to the joint to improve lubrication. According to researchers, this could also encourage the joint’s own hyaluronic acid synthesis.
For more details visit
https://www.databridgemarketresearch.com/reports/global-viscosupplementation-market
Why could arthritis need viscosupplementation therapy?
You may have previously tried various arthritis therapies, such as corticosteroid injections and over-the-counter pain relievers. Viscosupplementation could be a wise decision to assist lessen your pain, stiffness, and swelling if you still experience noticeable symptoms. People with mild to moderate arthritis appear to respond to the medication the most. If you’re attempting to put off having surgery on your joint, the therapy could make the most sense for you.
Viscosupplementation is often used by medical professionals to treat osteoarthritis, but it may also be helpful for persons with some other types of arthritis, such as rheumatoid arthritis. If it is an option for your particular form of arthritis, you can discuss it with your healthcare professional.
Viscosupplementation Market Size and Growth
- During the expected period of 2022 to 2029, the global viscosupplementation market is anticipated to develop. According to Data Bridge Market Research’s analysis, the market would expand at a CAGR of 8.5% from 2022 to 2029. Another factor fueling the expansion of the global viscosupplementation market in the anticipate time frame is the development in technologically advance viscosupplementation therapies in the healthcare industry.
- The high cost of the procedures and their adverse effects, which include temporary injection pain, site pain, swelling, heat, and redness loss, will impede the market’s expansion. The adoption of strategic alliances by major market players, such as partnerships and acquisitions, presents a growth opportunity for the global viscosupplementation market.
- The global market for viscosupplementation is divided into different categories based on the source, age group, molecular weight, injection, end user, and distribution method. The growth in different sectors enables you to identify your primary application areas and the differences in your target markets as well as examine unique development pockets and market entry tactics.
About Us
Global market intelligence and consulting firm Data Bridge Market Research is committed to aiding its wide range of customers in achieving transformative growth by assisting them in making important business choices. Our corporate headquarters are in India, and we also have sales offices in the United States, the United Kingdom, and Japan. Players from more than 57 nations and several business sectors make up our clientele. Our extremely trustworthy and precise reports add value for clients. In addition, we commit to continuing to provide our clients with quantifiable, long-lasting outcomes by taking the lead in providing insights in numerous areas after COVID-19.
